CRISPR Therapeutics AG CRSP
NASDAQ CRSP
$49.99 -0.51 (-1.01%)
At close: Oct 22, 2026 · 4:00 PM EDT

CRISPR Therapeutics AG (CRSP) Convertible Debt (2015)

Updated

CRISPR Therapeutics AG (CRSP) reported Convertible Debt of $38.34 million for Q4 2015.

Analysis

CRISPR Therapeutics AG (CRSP) Convertible Debt (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn
10 CRISPR Therapeutics AG 4.81 Bn -3.89 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 38.34 Mn
API Access

CRISPR Therapeutics AG Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=CRSP&period=max&api_key=YOUR_API_KEY